Fidelis Capital Partners LLC Buys 1,271 Shares of The Cigna Group (NYSE:CI)

Fidelis Capital Partners LLC increased its stake in The Cigna Group (NYSE:CI) by 72.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,031 shares of the health services provider’s stock after purchasing an additional 1,271 shares during the period. Fidelis Capital Partners LLC’s holdings in The Cigna Group were worth $886,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. LGT Fund Management Co Ltd. lifted its stake in shares of The Cigna Group by 67.0% during the fourth quarter. LGT Fund Management Co Ltd. now owns 7,850 shares of the health services provider’s stock valued at $2,168,000 after acquiring an additional 3,150 shares during the period. Plato Investment Management Ltd raised its holdings in The Cigna Group by 15.7% during the 4th quarter. Plato Investment Management Ltd now owns 17,040 shares of the health services provider’s stock worth $4,723,000 after purchasing an additional 2,313 shares during the last quarter. SBI Securities Co. Ltd. bought a new stake in The Cigna Group during the 4th quarter worth about $93,000. Jones Financial Companies Lllp lifted its position in The Cigna Group by 65.6% during the 4th quarter. Jones Financial Companies Lllp now owns 27,887 shares of the health services provider’s stock valued at $7,701,000 after purchasing an additional 11,049 shares during the period. Finally, Asahi Life Asset Management CO. LTD. bought a new position in shares of The Cigna Group in the 4th quarter valued at about $428,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Trading Up 0.9 %

The Cigna Group stock opened at $311.50 on Tuesday. The company has a market cap of $86.64 billion, a price-to-earnings ratio of 25.45, a P/E/G ratio of 0.98 and a beta of 0.54. The firm has a 50-day moving average of $290.14 and a 200-day moving average of $318.34. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The Cigna Group has a one year low of $262.03 and a one year high of $370.83.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the business posted $6.79 EPS. On average, equities analysts expect that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a $1.51 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a dividend yield of 1.94%. The Cigna Group’s dividend payout ratio (DPR) is currently 49.35%.

Wall Street Analyst Weigh In

CI has been the subject of a number of recent research reports. Truist Financial dropped their price target on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a research note on Tuesday, February 4th. Wells Fargo & Company dropped their target price on shares of The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 4th. Morgan Stanley reduced their price target on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. Royal Bank of Canada set a $355.00 price objective on The Cigna Group in a report on Friday, January 31st. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $372.31.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.